Collection of peripheral blood stem cells following administration of paclitaxel, cyclophosphamide, and filgrastim in patients with breast and ovarian cancer

Biology of Blood and Marrow Transplantation

Volumn 3, Issue 2, 1997, Pages 83-90

  Weaver, Charles H ^a   Schwartzberg, Lee S ^a   Birch, Robert ^a   Greco, F Anthony ^a   Hainsworth, John ^a   Drapkin, Robert ^a   Campos, Luis ^a   Grapski, Richard ^a   Schwerkoske, John ^a   Lautersztain, Julio ^a   Hazelton, Bonni ^a   Schnell, Frederick ^a   Babcock, William ^a   Buckner, C Dean ^a,b  

^a Response Oncology Inc   (United States)

^b Response Oncology Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; PACLITAXEL; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; AGED; ARTICLE; BLOOD; BLOOD SAMPLING; BREAST TUMOR; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; FEMALE; HEMATOPOIETIC STEM CELL; HUMAN; METHODOLOGY; MIDDLE AGED; OVARY TUMOR;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLOOD SPECIMEN COLLECTION; BREAST NEOPLASMS; CYCLOPHOSPHAMIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FILGRASTIM; HEMATOPOIETIC STEM CELLS; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; PACLITAXEL;

EID: 0031157727     PISSN: 10838791     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Bensinger WI, Singer J, Appelbaum F, Lilleby K, Longin K, Rowley S, Clark E, Clift R, Hansen J, Shieds T, Storb R, Weaver CH, Weiden P, Buckner CD: Autologous transplantation with peripheral blood mononuclear cells collected after administration of recombinant granulocyte stimulating factor. Blood 81:3158, 1993.
2. Bensinger WI, Longin K, Appelbaum F, Rowley S, Weaver C, Lilleby K, Gooley T, Lynch M, Higano T, Klarnet J, Chauncey T, Storb R, Buckner CD: Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony stimulating factor (rhG-CSF): An analysis of factors correlating with the tempo of engraftment after transplantation. Br J Haematol 87:825, 1994.
3. Bensinger W, Appelbaum F, Rowley S, Storb R, Sanders J, Lilleby K, Gooley T, Demirer T, Schiffman K, Weaver C, Clift R, Chauncey T, Klarnet J, Montgomery P, Petersdorf S, Weiden P, Witherspoon R, Buckner CD: Factors that influence collection and engraftment of autologous peripheral-blood stem cells. J Clin Oncol 13:2547, 1995.
4. Demirer T, Buckner CD, Bensinger WI: Optimization of peripheral blood stem cell mobilization. Stem Cells 14:106, 1996.
5. To LB, Shepperd M, Haylock DN, Dyson PG, Charles P, Thorp DL, Dale BM, Dart GW, Roberts MM, Sage RE, Juttner CA: Single high doses of cyclophosphamide enable the collection of high numbers of hemopoietic stem cells from the peripheral blood. Exp Hematol 18:442, 1990.
6. Kotasek D, Shepherd KM, Sage RE, Dale BM, Norman JE, Charles P, Gregg A, Pillow A, Bolton A: Factors affecting blood stem cell collections following high-dose cyclophosphamide mobilization in lymphoma, myeloma and solid tumors. Bone Marrow Transplant 9:11, 1992.
7. Schwartzberg L, Birch R, Hazelton B, Tauer K, Lee P, Altemose R, George C, Blanco R, Wittlin F, Cohen J, Muscato J, West W: Peripheral blood stem cell mobilization by chemotherapy with and without recombinant human granulocyte colony-stimulating factor. J Hematother 1:317, 1992.
8. Passos-Coelho JL, Braine HG, Davis JM, Huelskamp AM, Schepers KG, Ohly K, Clarke B, Wright SK, Noga SJ, Davidson NE, Kennedy MJ: Predictive factors for peripheral-blood progenitor-cell collections using a single large-volume leukapheresis after cyclophosphamide and granulocyte-macrophage colony-stimulating factor mobilization. J Clin Oncol 13:705, 1995.
9. Janssen WE, Hiemenz J, Zorsky PE, Fields KK, Ballester O, Perkins J, Kronish L, Smilee R, Carter R, Rahn D, Elfenbein GJ: Mobilization of peripheral blood stem cells: Comparing cell collections from cyclophosphamide and growth factor based regimens. Proc Inter Soc Exp Hematol 21:1164, 1993.
10. Demirer T, Rowley S, Buckner CD, Appelbaum FR, Lilleby K, Storb R, Schiffman K, Bensinger WI: Peripheral blood stem-cell collections after paclitaxel, cyclophosphamide and recombinant human granulocyte colony-stimulating factor in patients with breast and ovarian cancer. J Clin Oncol 13:1714, 1995.
11. Peters WP, Ross M, Vredenburgh JJ, Meisenberg B, Marks LB, Winer E, Kurtzberg J, Bast RC, Jr., Jones R, Shpall E, Wu K, Rosner G, Gilbert C, Mathias B, Coniglio D, Petros W, Henderson IC, Norton L, Weiss RB, Budman D, Hurd D: High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer. J Clin Oncol 11:1132, 1993.
12. Cannistra SA: Cancer of the ovary. New Engl J Med 329:1550, 1993.
13. Weaver C, Birch R, Schwartzberg L, West W: High-dose chemotherapy and autologous stem cell transplantation for breast cancer. In: CD Buckner, R Clift (eds): Technical and biological components of marrow transplantation. Boston, MA, Kluwer Academic Publishers, 59, 1995.
14. Fennelly D, Schneider J: Role of chemotherapy dose intensification in the treatment of advanced ovarian cancer. Oncology 9:911, 1995.
15. Ayash LJ, Wheeler C, Fairclough D, Schwartz G, Reich E, Warren D, Schnipper L, Antman K, Frei E, III, Elias A: Prognostic factors for prolonged progression-free survival with high-dose chemotherapy with autologous stem-cell support for advanced breast cancer. J Clin Oncol 13:2043, 1995.
16. Ozols RF: USA update on paclitaxel in ovarian cancer. Annals of Medicine 27:127, 1995.
17. Seidman AD, Hudis CA, Norton L: Memorial Sloan-Kettering Cancer Center experience with paclitaxel in the treatment of breast cancer: From advanced disease to adjuvant therapy. Semin Oncol 22:3, 1995.
18. + peripheral blood progenitor cells (PBPC) in patients with responding metastatic breast cancer (MBC) undergoing high dose chemotherapy. 31st Annual Meeting of the American Society of Clinical Oncology 14:313, 1995 (abstract).
19. Fennelly D, Schneider J, Spriggs D, Bengala C, Hakes T, Reich L, Barakat R, Curtin J, Moore MAS, Hoskins W, Norton L, Crown J: Dose escalation of paclitaxel with high-dose cyclophosphamide, with analysis of progenitor-cell mobilization and hematologic support. J Clin Oncol 13:1160, 1995.
20. Weaver CH, Hazelton B, Birch R, Palmer P, Allen C, Schwartzberg L, West W: An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy. Blood 86:3961, 1995.
21. Weaver CH, West WH, Schwartzberg LS, Birch R, McAneny B, Buckner CD: Induction, mobilization of peripheral blood stem cells (PBSC), high-dose chemotherapy and PBSC infusion in patients with untreated stage IV breast cancer: Outcomes by intent to treat analyses. Bone Marrow Transplant 19:661, 1997.
22. Wearer CH, Bensinger WI, Appelbaum K, Lilleby K, Sandmaier B, Brunvand M, Rowley S, Petersdorf S, Rivkin S, Gooley T, Weiden P, Zuckerman N, Montgomery P, Trueblood K, Klarnet J, Buckner CD: Phase I study of high-dose busulfan, melphalan, thiotepa with autologous stem cell support in patients with refractory malignancies. Bone Marrow Transplant 14:813, 1994.
23. Schiffman KS, Bensinger WI, Appelbaum FR, Rowley S, Lilleby K, Clift RA, Weaver CH, Demirer T, Sanders JE, Petersdorf S, Gooley T, Weiden P, Zuckerman N, Montgomery P, Maziarz R, Klarnet JP, Rivkin S, Trueblood K, Storb R, Holmberg L, Buckner CD: Phase II study of high-dose busulfan, melphalan and thiotepa with autologous peripheral blood stem cell support in patients with malignant disease. Bone Marrow Transplant 17:943, 1996.
24. Weaver CH, Wittlin F, Lexis M, Schwartzberg LS, Li W, Palmer P: A phase I trial of high-dose melphalan, mitoxantrone and carboplatin in patients with ovarian and breast cancer. Proc Am Soc Hematol 86: 973a, 1995 (abstract).
25. Green S, Weiss GR: Southwest Oncology Group standard response criteria, endpoint definitions and toxicity criteria. Invest New Drugs 10:239, 1992.
26. Draper N, Smith H: Selecting the "best" regression equation. In: RA Bradley, JS Hunter, DG Kendall, GS Watson (eds): Applied regression analysis, second edition, Wiley series in probability and mathematical statistics, second edition. New York, John Wiley and Sons, 307, 1981.
27. Cox DR: Regression models and life-tables. J Royal Stat Soc Series B 34:187, 1972.
28. Haas R, Möble R, Frübauf S, Goldschmidt H, Witt B, Flentje M, Wannenmacher M, Hunstein W: Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood 83:3787, 1994.
29. Damirer T, Buckner CD, Storer B, Lilleby K, Rowley S, Clift R, Appelbaum FR, Storb R, Bensinger WI: The effect of different chemotherapy regimens on peripheral blood stem cell collections in patients with breast cancer receiving granulocyte-colony stimulating factor. J Clin Oncol 15:684, 1997.
30. Raptis G, Vahdat L, Hamilton N, Fennelly D, Norton L, Crown J: High complete remission (CR) rate with accelerated multicycle high-dose chemotherapy (HDC) in patients (PTS) with metastatic breast cancer (MBC). Proc Am Soc Clin Oncol 14:322, 1995 (abstract).
31. Brugger W, Bross K, Frisch J, Dern P, Weber B, Mertelsmann R, Kanz L: Mobilization of peripheral blood progenitor cells by sequential administration of interleukin-3 and granulocyte-macrophage colony-stimulating factor following poly-chemotherapy with etoposide, ifosfamide and cisplatin. Blood 79:1193, 1992.
32. Tricot G, Jagannath S, Vesole D, Nelson J, Tindle S, Miller L, Cheson B, Crowley J, Barlogie B: Peripheral blood stem cell transplants for multiple myeloma: Identification of favorable variables for rapid engraftment in 225 patients. Blood 85:588, 1995.